Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Mar;79(9-10):1356–1365. doi: 10.1038/sj.bjc.6690218

New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies

F Orosz 1, B Comin 2, B Raïs 2, J Puigjaner 2, J Kovács 3, G Tárkányi 4, T Ács 4, T Keve 4, M Cascante 2, J Ovádi 1
PMCID: PMC2362735  PMID: 10188876

Abstract

A new semisynthetic anti-tumour bis-indol compound, KAR-2 [3′-(β-chloroethyl)-2′,4′-dioxo-3,5′-spiro-oxazolidino-4-deacetoxy-vinblastine] with lower toxicity than vinca alkaloids used in chemotherapy binds to calmodulin but, in contrast to vinblastine, does not exhibit anti-calmodulin activity. To investigate whether the modest chemical modification of bis-indol structure is responsible for the lack of anti-calmodulin potency and for the different pharmacological effects, new derivatives have been synthesized for comparative studies. The synthesis of the KAR derivatives are presented. The comparative studies showed that the spiro-oxazolidino ring and the substitution of a formyl group to a methyl one were responsible for the lack of anti-calmodulin activities. The new derivatives, similar to the mother compounds, inhibited the tubulin assembly in polymerization tests in vitro, however their inhibitory effect was highly dependent on the organization state of microtubules; bundled microtubules appeared to be resistant against the drugs. The maximal cytotoxic activities of KAR derivatives in in vivo mice hosting leukaemia P388 or Ehrlich ascites tumour cells appeared similar to that of vinblastine or vincristine, however significant prolongation of life span could be reached with KAR derivatives only after the administration of a single dose. These studies plus data obtained using a cultured human neuroblastoma cell line showed that KAR compounds displayed their cytotoxic activities at significantly higher concentrations than the mother compounds, although their antimicrotubular activities were similar in vitro. These data suggest that vinblastine/vincristine damage additional crucial cell functions, one of which could be related to calmodulin-mediated processes. © 1999 Cancer Research Campaign

Keywords: vinca alaloid, bis-indol, vinblastine, vincristine, microtubule, calmodulin, antagonism

Full Text

The Full Text of this article is available as a PDF (189.3 KB).

Footnotes

*1H and 13C chemical shift data for the sulphuric acid salts of compounds KAR-2, KAR-3 and KAR-4 will be published elsewhere.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alley M. C., Scudiero D. A., Monks A., Hursey M. L., Czerwinski M. J., Fine D. L., Abbott B. J., Mayo J. G., Shoemaker R. H., Boyd M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988 Feb 1;48(3):589–601. [PubMed] [Google Scholar]
  2. Codaccioni F., Dell'Amico M., Bourdeaux M., Briand C., Lux B. Influence of the guanine nucleotide phosphorylation state and of Mg2+ ions on the interaction of vinzolidine/tubulin 6 S: a fluorescence quenching study. Arch Biochem Biophys. 1988 Nov 15;267(1):236–244. doi: 10.1016/0003-9861(88)90028-8. [DOI] [PubMed] [Google Scholar]
  3. Cros S., Wright M., Morimoto M., Lataste H., Couzinier J. P., Krikorian A. Experimental antitumor activity of Navelbine. Semin Oncol. 1989 Apr;16(2 Suppl 4):15–20. [PubMed] [Google Scholar]
  4. Durrieu C., Bernier-Valentin F., Rousset B. Binding of glyceraldehyde 3-phosphate dehydrogenase to microtubules. Mol Cell Biochem. 1987 Mar;74(1):55–65. doi: 10.1007/BF00221912. [DOI] [PubMed] [Google Scholar]
  5. Gopalakrishna R., Anderson W. B. Ca2+-induced hydrophobic site on calmodulin: application for purification of calmodulin by phenyl-Sepharose affinity chromatography. Biochem Biophys Res Commun. 1982 Jan 29;104(2):830–836. doi: 10.1016/0006-291x(82)90712-4. [DOI] [PubMed] [Google Scholar]
  6. Hesterberg L. K., Lee J. C. Self-association of rabbit muscle phosphofructokinase: effects of ligands. Biochemistry. 1982 Jan 19;21(2):216–222. doi: 10.1021/bi00531a003. [DOI] [PubMed] [Google Scholar]
  7. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  8. Lathan B., Clark G. M., Von Hoff D. D. In vitro comparison of vinzolidine and vinblastine: a model for methods of evaluation of analogues in a human tumor cloning system. Cancer Res. 1985 Dec;45(12 Pt 1):6286–6289. [PubMed] [Google Scholar]
  9. Lehotzky A., Pálfia Z., Kovács J., Molnár A., Ovádi J. Ligand-modulated cross-bridging of microtubules by phosphofructokinase. Biochem Biophys Res Commun. 1994 Oct 28;204(2):585–591. doi: 10.1006/bbrc.1994.2499. [DOI] [PubMed] [Google Scholar]
  10. Lehotzky A., Telegdi M., Liliom K., Ovádi J. Interaction of phosphofructokinase with tubulin and microtubules. Quantitative evaluation of the mutual effects. J Biol Chem. 1993 May 25;268(15):10888–10894. [PubMed] [Google Scholar]
  11. Liliom K., Lehotzky A., Molnár A., Ovádi J. Characterization of tubulin-alkaloid interactions by enzyme-linked immunosorbent assay. Anal Biochem. 1995 Jun 10;228(1):18–26. doi: 10.1006/abio.1995.1309. [DOI] [PubMed] [Google Scholar]
  12. Lin C. M., Singh S. B., Chu P. S., Dempcy R. O., Schmidt J. M., Pettit G. R., Hamel E. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Mol Pharmacol. 1988 Aug;34(2):200–208. [PubMed] [Google Scholar]
  13. Mayr G. W. Interaction of calmodulin with phosphofructokinase: binding studies and evaluation of enzymatic and physicochemical changes. Methods Enzymol. 1987;139:745–763. doi: 10.1016/0076-6879(87)39124-4. [DOI] [PubMed] [Google Scholar]
  14. Molnár A., Liliom K., Orosz F., Vértessy B. G., Ovádi J. Anti-calmodulin potency of indol alkaloids in in vitro systems. Eur J Pharmacol. 1995 Oct 15;291(2):73–82. doi: 10.1016/0922-4106(95)90127-2. [DOI] [PubMed] [Google Scholar]
  15. Na G. C., Timasheff S. N. Interaction of vinblastine with calf brain tubulin: multiple equilibria. Biochemistry. 1986 Oct 7;25(20):6214–6222. doi: 10.1021/bi00368a057. [DOI] [PubMed] [Google Scholar]
  16. Orosz F., Christova T. Y., Ovádi J. Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes. Mol Pharmacol. 1988 Jun;33(6):678–682. [PubMed] [Google Scholar]
  17. Orosz F., Kovács J., Löw P., Vértessy B. G., Urbányi Z., Acs T., Keve T., Ovádi J. Interaction of a new bis-indol derivative, KAR-2 with tubulin and its antimitotic activity. Br J Pharmacol. 1997 Jul;121(5):947–954. doi: 10.1038/sj.bjp.0701189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Orosz F., Telegdi M., Liliom K., Solti M., Korbonits D., Ovádi J. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis. Mol Pharmacol. 1990 Dec;38(6):910–916. [PubMed] [Google Scholar]
  19. Orosz F., Vértessy B. G., Salerno C., Crifo C., Capuozzo E., Ovádi J. The interaction of a new anti-tumour drug, KAR-2 with calmodulin. Br J Pharmacol. 1997 Jul;121(5):955–962. doi: 10.1038/sj.bjp.0701190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ovádi J. Effects of drugs on calmodulin-mediated enzymatic actions. Prog Drug Res. 1989;33:353–395. doi: 10.1007/978-3-0348-9146-2_11. [DOI] [PubMed] [Google Scholar]
  21. Schiff P. B., Fant J., Horwitz S. B. Promotion of microtubule assembly in vitro by taxol. Nature. 1979 Feb 22;277(5698):665–667. doi: 10.1038/277665a0. [DOI] [PubMed] [Google Scholar]
  22. Schneider F. Die aerobe Glykolyse der Tumorzelle. Naturwissenschaften. 1981 Jan;68(1):20–27. doi: 10.1007/BF01047157. [DOI] [PubMed] [Google Scholar]
  23. Solti M., Dévay P., Kiss I., Londesborough J., Friedrich P. Cyclic nucleotide phosphodiesterases in larval brain of wild type and dunce mutant strains of Drosophila melanogaster: isoenzyme pattern and activation by Ca2+/calmodulin. Biochem Biophys Res Commun. 1983 Mar 16;111(2):652–658. doi: 10.1016/0006-291x(83)90356-x. [DOI] [PubMed] [Google Scholar]
  24. Vértessy B. G., Kovács J., Löw P., Lehotzky A., Molnár A., Orosz F., Ovádi J. Characterization of microtubule-phosphofructokinase complex: specific effects of MgATP and vinblastine. Biochemistry. 1997 Feb 25;36(8):2051–2062. doi: 10.1021/bi9623441. [DOI] [PubMed] [Google Scholar]
  25. Vértessy B. G., Kovács J., Ovádi J. Specific characteristics of phosphofructokinase-microtubule interaction. FEBS Lett. 1996 Jan 29;379(2):191–195. doi: 10.1016/0014-5793(95)01510-8. [DOI] [PubMed] [Google Scholar]
  26. Watterson D. M., Harrelson W. G., Jr, Keller P. M., Sharief F., Vanaman T. C. Structural similarities between the Ca2+-dependent regulatory proteins of 3':5'-cyclic nucleotide phosphodiesterase and actomyosin ATPase. J Biol Chem. 1976 Aug 10;251(15):4501–4513. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES